Zhejiang Nhu Co Ltd (002001) - Total Assets

Latest as of March 2026: CN¥47.45 Billion CNY ≈ $6.94 Billion USD

Based on the latest financial reports, Zhejiang Nhu Co Ltd (002001) holds total assets worth CN¥47.45 Billion CNY (≈ $6.94 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check 002001 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Zhejiang Nhu Co Ltd - Total Assets Trend (2001–2025)

This chart illustrates how Zhejiang Nhu Co Ltd's total assets have evolved over time, based on quarterly financial data. Explore Zhejiang Nhu Co Ltd (002001) long-term investment share to see how much of total assets are deployed in long-term investments.

Zhejiang Nhu Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2025)

Zhejiang Nhu Co Ltd's total assets of CN¥47.45 Billion consist of 42.6% current assets and 57.4% non-current assets.

Asset Category Amount (CNY) % of Total Assets
Cash & Equivalents CN¥0.00 17.5%
Accounts Receivable CN¥3.33 Billion 7.3%
Inventory CN¥4.65 Billion 10.2%
Property, Plant & Equipment CN¥0.00 0.0%
Intangible Assets CN¥2.59 Billion 5.7%
Goodwill CN¥3.62 Million 0.0%

Asset Composition Trend (2001–2025)

This chart illustrates how Zhejiang Nhu Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Zhejiang Nhu Co Ltd market cap and net worth.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Zhejiang Nhu Co Ltd's current assets represent 42.6% of total assets in 2025, a decrease from 53.7% in 2001.
  • Cash Position: Cash and equivalents constituted 17.5% of total assets in 2025, up from 17.1% in 2001.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, an increase from 3.0% in 2001.
  • Asset Diversification: The largest asset category is inventory at 10.2% of total assets.

Zhejiang Nhu Co Ltd Competitors by Total Assets

Key competitors of Zhejiang Nhu Co Ltd based on total assets are shown below.

Company Country Total Assets
GALDERMA GROUP AG
NYSE:GALDY
USA $13.39 Billion
Changchun High & New Technology Industries Group Inc
SHE:000661
China CN¥30.77 Billion
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
China CN¥17.84 Billion
Tianjin Zhongxin Pharmaceutical Group Corp Ltd
SHG:600329
China CN¥11.59 Billion
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
China CN¥5.17 Billion
Dermapharm Holding SE
XETRA:DMP
Germany €2.27 Billion
China Animal Husbandry Industry Co Ltd
SHG:600195
China CN¥9.32 Billion
Daewoong Pharma
KO:069620
Korea ₩2.26 Trillion

Zhejiang Nhu Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 2.82 2.61 2.35
Quick Ratio 2.24 1.99 1.81
Cash Ratio 0.00 0.00 0.00
Working Capital CN¥13.90 Billion CN¥11.12 Billion CN¥8.82 Billion

Zhejiang Nhu Co Ltd - Advanced Valuation Insights

This section examines the relationship between Zhejiang Nhu Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.78
Latest Market Cap to Assets Ratio 0.28
Asset Growth Rate (YoY) 6.1%
Total Assets CN¥45.61 Billion
Market Capitalization $12.59 Billion USD

Valuation Analysis

Below Book Valuation: The market values Zhejiang Nhu Co Ltd's assets below their book value (0.28x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Zhejiang Nhu Co Ltd's assets grew by 6.1% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Zhejiang Nhu Co Ltd (2001–2025)

The table below shows the annual total assets of Zhejiang Nhu Co Ltd from 2001 to 2025.

Year Total Assets Change
2025-12-31 CN¥45.61 Billion
≈ $6.67 Billion
+6.09%
2024-12-31 CN¥42.99 Billion
≈ $6.29 Billion
+9.79%
2023-12-31 CN¥39.16 Billion
≈ $5.73 Billion
+2.32%
2022-12-31 CN¥38.27 Billion
≈ $5.60 Billion
+10.21%
2021-12-31 CN¥34.72 Billion
≈ $5.08 Billion
+12.38%
2020-12-31 CN¥30.90 Billion
≈ $4.52 Billion
+7.58%
2019-12-31 CN¥28.72 Billion
≈ $4.20 Billion
+30.95%
2018-12-31 CN¥21.93 Billion
≈ $3.21 Billion
+20.64%
2017-12-31 CN¥18.18 Billion
≈ $2.66 Billion
+59.35%
2016-12-31 CN¥11.41 Billion
≈ $1.67 Billion
+17.34%
2015-12-31 CN¥9.72 Billion
≈ $1.42 Billion
+6.58%
2014-12-31 CN¥9.12 Billion
≈ $1.34 Billion
+6.64%
2013-12-31 CN¥8.56 Billion
≈ $1.25 Billion
+9.20%
2012-12-31 CN¥7.84 Billion
≈ $1.15 Billion
+9.56%
2011-12-31 CN¥7.15 Billion
≈ $1.05 Billion
+16.22%
2010-12-31 CN¥6.15 Billion
≈ $900.40 Million
+46.17%
2009-12-31 CN¥4.21 Billion
≈ $616.02 Million
+13.30%
2008-12-31 CN¥3.72 Billion
≈ $543.70 Million
+46.94%
2007-12-31 CN¥2.53 Billion
≈ $370.01 Million
+4.94%
2006-12-31 CN¥2.41 Billion
≈ $352.59 Million
+21.20%
2005-12-31 CN¥1.99 Billion
≈ $290.92 Million
+24.49%
2004-12-31 CN¥1.60 Billion
≈ $233.69 Million
+51.88%
2003-12-31 CN¥1.05 Billion
≈ $153.86 Million
+24.64%
2002-12-31 CN¥843.61 Million
≈ $123.45 Million
-1.15%
2001-12-31 CN¥853.45 Million
≈ $124.89 Million
--

About Zhejiang Nhu Co Ltd

SHE:002001 China Drug Manufacturers - Specialty & Generic
Market Cap
$12.59 Billion
CN¥86.06 Billion CNY
Market Cap Rank
#1894 Global
#213 in China
Share Price
CN¥28.00
Change (1 day)
-1.75%
52-Week Range
CN¥21.23 - CN¥39.30
All Time High
CN¥69.69
About

Zhejiang NHU Company Ltd., together with its subsidiaries, produces and sells nutritional products, fragrances and flavors, polymer materials, and active pharmaceutical ingredients in China and internationally. It operates through Pharmaceutical and Chemical; and Other segments. The company offers animal nutrition products comprising vitamins, amino acids, and carotenoids for poultry, swine, rumi… Read more